Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Specimen Handling 642 pembrolizumab 565 Magnetic Resonance Spectroscopy 548 Carboplatin 426 Cisplatin 377 Cyclophosphamide 374 Biopsy 365 Paclitaxel 306 Nivolumab 303 Gemcitabine 303 Radiotherapy 274 Bevacizumab 240 Dexamethasone 209 fludarabine 207 Docetaxel 191 durvalumab 183 atezolizumab 177 Oxaliplatin 174 venetoclax 168 Fluorouracil 167 Rituximab 166 Pemetrexed 164 Capecitabine 161 Radiation 159 Doxorubicin 159 Radiosurgery 150 Etoposide 137 Ipilimumab 135 Leucovorin 133 Lenalidomide 132

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interleukin-11 × 90 days × Clear all

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡